Skip to main content
IDWeek 2021 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
View Session ViewAttendees 61

Adult ID

Global ID

Investigative ID

Pediatric ID

Trainee

Transplant

COVID
Symposium

16 - Science of COVID vaccines

Thursday, September 30, 2021
11:00 AM - 12:15 PM EDT

    Moderator(s)

  • Nadine Rouphael, MD

    Professor of Medicine- Director of the Hope Clinic
    Emory University
    Atlanta, GA, United States

    Lilly (Individual(s) Involved: Self): Emory Study PI, Grant/Research Support; Merck (Individual(s) Involved: Self): Emory study PI, Grant/Research Support; Pfizer: I conduct as co-PI the RSV PFIZER study at Emory, Research Grant; Pfizer (Individual(s) Involved: Self): Grant/Research Support, I conduct as co-PI the RSV PFIZER study at Emory; Quidel (Individual(s) Involved: Self): Emory Study PI, Grant/Research Support; Sanofi Pasteur (Individual(s) Involved: Self): Chair phase 3 COVID vaccine, Grant/Research Support

  • Kathleen Neuzil, MD, MPH, FIDSA, FACP

    Director of the Center for Vaccine Development and Global Health
    University of Maryland
    Baltmore, Maryland, United States

    I do not have any relevant financial / non-financial relationships with any proprietary interests.

    • Speaker(s)

  • Christine Dahlke, PhD

    Senior Post Doc
    Universitätsklinikum Hamburg Eppendorf
    Hamburg, Germany

    I do not have any relevant financial / non-financial relationships with any proprietary interests.

  • KS

    Kathryn Stephenson, MD, MPH

    Assistant Professor of Medicine
    Harvard Medical School
    Boston, MA, United States

    I do not have any relevant financial / non-financial relationships with any proprietary interests.

  • Penny Moore, PhD

    South African Research Chair in Virus-Host Dynamics
    University of the Witwatersrand and National Institute for Communicable Diseases
    Sandringham, South Africa

    I do not have any relevant financial / non-financial relationships with any proprietary interests.

  • HJ

    Holly Janes, PhD

    Professor
    Fred Hutchinson Cancer Research Center
    Seattle, WA, United States

    I do not have any relevant financial / non-financial relationships with any proprietary interests.

Participants should be aware of the following financial/non-financial relationships:
Nadine Rouphael, MD: Lilly (Individual(s) Involved: Self): Emory Study PI, Grant/Research Support; Merck (Individual(s) Involved: Self): Emory study PI, Grant/Research Support; Pfizer: I conduct as co-PI the RSV PFIZER study at Emory, Research Grant; Pfizer (Individual(s) Involved: Self): Grant/Research Support, I conduct as co-PI the RSV PFIZER study at Emory; Quidel (Individual(s) Involved: Self): Emory Study PI, Grant/Research Support; Sanofi Pasteur (Individual(s) Involved: Self): Chair phase 3 COVID vaccine, Grant/Research Support
Kathleen M. Neuzil, MD, MPH, FIDSA, FACP: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Christine Dahlke, PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Kathryn E. Stephenson, MD, MPH: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Penny Moore, PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Holly Janes, PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
ACPE Credits: ACPE 1.25 Knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-0000-21-001-H01-P

Learning Objectives:

At the conclusion of this session, participants will be able to:
  • identify the impact of variants of concern on SARS-CoV-2 vaccine responses
  • explain the correlates of prorection of different SARS-CoV-2 vaccines
  • discuss vaccine design of new vaccines against COVID-19

Presentations:

  • Correlates of Protection for COVID-19 Vaccines

    Speaker: Christine Dahlke, PhD – Universitätsklinikum Hamburg Eppendorf

  • Effects of COVID-19 Vaccines on Asymptomatic Infection, Viral Load and Transmission

    Speaker: Kathryn E. Stephenson, MD, MPH – Harvard Medical School

  • Humoral Response to SARS-CoV-2 Variants

    Speaker: Penny Moore, PhD – University of the Witwatersrand and National Institute for Communicable Diseases

  • SARS-CoV-2 vaccine design

    Speaker: Holly Janes, PhD – Fred Hutchinson Cancer Research Center